糖皮质激素治疗老年肺源性心脏病的效果研讨

Effects of glucocorticoid on senile pulmonary heart disease

目的:探讨用糖皮质激素治疗老年肺源性心脏病的临床效果。方法:选择2016年1月至2017年1月期间在江安县人民医院接受治疗的46例老年肺源性心脏病患者作为研究对象。按照随机数表法将这46例患者分为参照组和治疗组,每组各有23例患者。对两组患者均进行常规治疗。在此基础上,为治疗组患者使用糖皮质激素进行治疗。然后,比较两组患者治疗前、治疗3 d后、治疗7 d后其Pa O_2(动脉血氧分压)的水平、Pa CO_2(血二氧化碳分压)的水平及治疗的总有效率。结果:治疗7 d后,治疗组患者Pa O_2的水平高于参照组患者,其Pa CO_2的水平低于参照组患者,其治疗的总有效率高于参照组患者,差异有统计学意义(P<0.05)。结论:用糖皮质激素治疗老年肺源性心脏病的临床效果显著,可有效地改善患者的血气指标。

objective： to explore the clinical effect of glucocorticoid in the treatment of senile pulmonary heart disease. Methods： 46 elderly patients with pulmonary heart disease who received treatment in jiang ‘an people＇s hospital from January 2016 to January 2017 were selected as subjects. The 46 patients were divided into the reference group and the treatment group according to the random table method, with 23 patients in each group. Both groups were treated routinely. On this basis, patients in the treatment group were treated with glucocorticoid. Then, the levels of PaO2（arterial oxygen partial pressure）, PaCO2（blood carbon dioxide partial pressure） and the total effective rate of treatment were compared between the two groups before treatment, 3 d after treatment and 7 d after treatment. Results： after 7 days of treatment, the level of PaO2 in the treatment group was higher than that in the reference group, the level of PaCO2 in the treatment group was lower than that in the reference group, and the total therapeutic efficiency was higher than that in the reference group, with statistically significant differences（P〈0.05）. Conclusion： glucocorticoid is effective in treating senile pulmonary heart disease.